Skip to main content
. Author manuscript; available in PMC: 2018 Sep 1.
Published in final edited form as: Clin Pharmacol Ther. 2017 May 30;102(3):529–536. doi: 10.1002/cpt.667

Figure 1. Levonorgestrel AUC0–24weeks within the efavirenz group shown by statistically significant genotype.

Figure 1

Levonorgestrel AUC0–24weeks compared by statistically significant genotype.

Data is represented by median (interquartile range) and compared by genotype for each of the single nucleotide polymorphisms (SNPs) significantly associated levonorgestrel log10 AUC0–24weeks found through multivariate analysis (P=0.05) within the efavirenz group.